Cover Image

Severe recalcitrant cutaneous eruption with dual immune checkpoint blockade

Saved in:

Bibliographic Details
Main Authors:	Sakeena Fatima, BA (Author), Jesse Veenstra, MD, PhD (Author), Albert S. Antonyan, MD (Author), Laurie Kohen, MD (Author)
Format:	Book
Published:	Elsevier, 2018-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tumor lysis syndrome and collateral immune activation in dual checkpoint blockade
by: Risa Konishi, et al.
Published: (2021)

Lichenoid tissue eruption of the vulva associated with immune checkpoint inhibitor
by: Maya I. Davis, BA, et al.
Published: (2024)

Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade
by: David M. Miller, MD, PhD, et al.
Published: (2017)

Formation of eruptive cutaneous squamous cell carcinomas after programmed cell death protein-1 blockade
by: Rachel L. Marsh, BA, et al.
Published: (2020)

Immune checkpoint blockade therapy in head and neck cancer: a review
by: Shajedul Islam, et al.
Published: (2018)

Predictive factors of neoadjuvant immune checkpoint blockade in melanoma
by: Melissa Sarver, et al.
Published: (2022)

Recalcitrant facial rash: Cutaneous coccidioidomycosis
by: Shanice A. McKenzie, BS, et al.
Published: (2020)

Oral tofacitinib citrate for recalcitrant cutaneous lupus
by: Evelyne Bonnardeaux, MD, et al.
Published: (2022)

Green palmoplantar vesicular eruption in a patient with hyperbilirubinemia
by: Miranda Uzoma, MD, et al.
Published: (2017)

The use of dual biologic therapy for the management of recalcitrant psoriasis
by: Paula Finnegan, BA, MB, BAO, BCh, MRCPI, et al.
Published: (2024)

Recalcitrant cutaneous sarcoidosis treated with upadacitinib: Case report
by: Mohannad Safadi, MD, et al.
Published: (2024)

Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis
by: Yantao Xu, et al.
Published: (2022)

Mechanistic basis for Cancer Immune Evasion and role of immune checkpoint blockades in Immuno-Oncology
by: Benjamin A Babalola, et al.
Published: (2021)

Combinatorial Approaches to Enhance Anti-Tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
Published: (2019)

Scarring Alopecia Under Immune Checkpoint Blockade: a Report of Three Cases
by: Sonja Braasch, et al.
Published: (2022)

Localized bullous pemphigoid in a melanoma patient with dual exposure to PD-1 checkpoint inhibition and radiation therapy
by: Kelsey Hirotsu, MD, et al.
Published: (2017)

Sustained remission of recalcitrant cutaneous lymphoid hyperplasia after thalidomide treatment
by: Stephen P. Erickson, BS, et al.
Published: (2018)

The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study
by: Jade N. Young, BS, et al.
Published: (2024)

Erythema nodosum-like panniculitis associated with immune checkpoint inhibitor therapy: Two cases reporting a rare cutaneous adverse event
by: Jolanta Pach, BA, et al.
Published: (2021)

Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model
by: Mathilde Bausart, et al.
Published: (2022)

Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles
by: Yuxuan Liu, et al.
Published: (2024)

Recalcitrant generalized pustular eruption after diltiazem
by: Sridhar Jandhyala, et al.
Published: (2012)

27 HIV-associated gastrointestinal microbial dysbiosis influences the efficacy of anti-HIV immunity by immune checkpoint blockade
by: I.N. SahBandar, et al.
Published: (2017)

Oral tacrolimus for severe recalcitrant eosinophilic cellulitis
by: Mirmovich Morvay, MD, et al.
Published: (2020)

Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors
by: Qiuyu Wu, et al.
Published: (2023)

Potential tactics with vitamin D and certain phytochemicals for enhancing the effectiveness of immune-checkpoint blockade therapies
by: Ai Tsuji, et al.
Published: (2023)

Recalcitrant palmoplantar pustulosis controlled with dupilumab
by: Hannah D. Smith, BA, et al.
Published: (2023)

Immune checkpoint inhibitor therapy in a liver transplant recipient with autoimmune disease and metastatic cutaneous squamous cell carcinoma
by: Caitlin M. Brumfiel, MS, et al.
Published: (2021)

Cutaneous eruption in neonate with congenital heart defect
by: Justin Raman, BS, et al.
Published: (2022)

Recalcitrant cutaneous pyoderma gangrenosum with pulmonary involvement resolved with treatment of underlying plasma cell dyscrasia
by: Tyler A. Hooton, MD, et al.
Published: (2021)

Cutaneous eruptions associated with monkeypox virus infection: A systematic review
by: Saleh Asaad, MD, et al.
Published: (2023)

Cutaneous drug eruptions associated with COVID-19 therapy
by: Laura Atzori, MD, et al.
Published: (2020)

Association of lichen sclerosus and morphea with immune checkpoint therapy: a systematic review
by: Leah Shin, BA, et al.
Published: (2023)

Mixed effects modeling of radiotherapy in combination with immune checkpoint blockade or inhibitors of the DNA damage response pathway
by: David Hodson, et al.
Published: (2023)

Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
by: Jiulong Zhang, et al.
Published: (2022)

A clinician's guide to cutaneous T-cell lymphoma presenting as recalcitrant eczematous dermatitis in adults
by: Sarah Semaan, BS, et al.
Published: (2021)

Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment
by: Taylor C. Duke, MD, et al.
Published: (2020)

Cutaneous eruption associated with Streptococcus dysgalactiae (group C Streptococcus) bacteremia
by: Hovik J. Ashchyan, BA, et al.
Published: (2017)

A case of primary cutaneous marginal zone lymphoma presenting with rosacea-like eruption
by: Tanvir Agnihotri, BA, et al.
Published: (2020)

Systemic tacrolimus in the treatment of recalcitrant mucosal lichen planus
by: Edward Chen, BA, et al.
Published: (2017)